BlackRock Institutional Trust’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$606M Buy
7,572,692
+149,792
+2% +$11.9M 0.09% 224
2016
Q3
$592M Buy
7,422,900
+63,599
+0.9% +$5.13M 0.09% 228
2016
Q2
$574M Sell
7,359,301
-34,082
-0.5% -$2.43M 0.09% 223
2016
Q1
$407M Buy
7,393,383
+100,767
+1% +$5.49M 0.07% 287
2015
Q4
$450M Buy
7,292,616
+133,148
+2% +$8.4M 0.07% 264
2015
Q3
$452M Sell
7,159,468
-60,669
-0.8% -$4.33M 0.08% 254
2015
Q2
$528M Sell
7,220,137
-531,133
-7% -$38.4M 0.08% 233
2015
Q1
$507M Sell
7,751,270
-988,366
-11% -$65.7M 0.08% 255
2014
Q4
$568M Sell
8,739,636
-272,185
-3% -$17.5M 0.09% 231
2014
Q3
$542M Buy
9,011,821
+654,418
+8% +$42.8M 0.09% 227
2014
Q2
$579M Sell
8,357,403
-654,252
-7% -$42.4M 0.1% 215
2014
Q1
$589M Buy
9,011,655
+1,514,250
+20% +$98.6M 0.1% 200
2013
Q4
$464M Buy
7,497,405
+35,507
+0.5% +$2.06M 0.08% 236
2013
Q3
$400M Sell
7,461,898
-173,016
-2% -$8.91M 0.08% 254
2013
Q2
$348M Buy
+7,634,914
New +$331M 0.07% 277

Other funds holding STJ

BlackRock Institutional Trust's STJ Position: Q4 2016 in Review

BlackRock Institutional Trust increased its St Jude Medical (STJ) stake by 2% in Q4 2016, buying an estimated $11.9M and bringing the position to 7,572,692 shares worth $606M. The position accounts for 0.09% of the portfolio, ranked #224.

BlackRock Institutional Trust first reported a position in STJ in Q2 2013 and has held it in 15 quarters since. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

  • BlackRock Institutional Trust held 7,572,692 shares of St Jude Medical worth $606M as of Q4 2016.
  • BlackRock Institutional Trust bought 149,792 St Jude Medical shares in Q4 2016, an estimated $11.9M.
  • St Jude Medical made up 0.09% of BlackRock Institutional Trust's portfolio in Q4 2016, its #224 holding.
  • BlackRock Institutional Trust first reported a position in St Jude Medical in Q2 2013 and has held it in 15 quarters since.
  • 551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.